Fundz

Aether Biomachines Raises $15M to Reindustrialize America with AI-Designed Proteins, led by Tribe Capital.

PRIVATEDec 03, 2025

Amount Raised

$15 Million

Round Type

Funding Round

San FranciscoManufacturingBiotechnologyArtificial IntelligenceMachine Learning

Investors

Radicle ImpactNatural CapitalShrug CapitalResilience ReserveHenkel Corporation4DX VenturesUnless PartnersTribe Capital

Description

Aether Biomachines has raised an additional $15 million in funding, led by Tribe Capital. This round brings Aether’s total funding to $64 million, aimed at expanding its AI-powered protein design. The company intends to scale its commercial materials products and enhance partnerships across various sectors. CEO Pavle Jeremić emphasizes this funding will help accelerate the discovery of transformative proteins.

Quick answer

Aether Biomachines raised $15 Million in a Funding Round round, dated December 3, 2025. Investors: Radicle Impact, Natural Capital, Shrug Capital, Resilience Reserve, Henkel Corporation, 4DX Ventures, Unless Partners and Tribe Capital. Aether Biomachines is based in San Francisco, California, United States.

How much did Aether Biomachines raise?
Aether Biomachines raised $15 Million in a Funding Round round on December 3, 2025.
Who invested in Aether Biomachines?
Radicle Impact, Natural Capital, Shrug Capital, Resilience Reserve, Henkel Corporation, 4DX Ventures, Unless Partners and Tribe Capital are named as investors in this round.
What does Aether Biomachines do?
Aether Biomachines is an American artificial intelligence company that discovers proteins with high-impact, real-world applications.
Where is Aether Biomachines based and how big is it?
Aether Biomachines is based in San Francisco, California, United States.
Who are the decision-makers at Aether Biomachines?
Fundz holds 2 contacts at Aether Biomachines, including the Chief Operating Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Aether Biomachines that raised within 45 days of this round, from Fundz verified event records.

  • Cursor raised $2.3B (Funding Round) on November 13, 2025.
  • Altrove raised $10M (Seed) on October 31, 2025.
  • Allos AI raised $5M (Seed) on January 12, 2026.
  • Qureator raised $6.7M on December 23, 2025.
  • Neural Concept raised $100M (Series C) on December 18, 2025.
  • Edison Scientific raised $70M (Seed) on December 18, 2025.

Who to call at Aether Biomachines, and when

A new round usually means Aether Biomachines is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aether Biomachines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aether Biomachines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aether Biomachines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aether Biomachines

Location

San Francisco, California, United States

About

Aether Biomachines is an American artificial intelligence company that discovers proteins with high-impact, real-world applications. At the core of its work is a Protein Function Model that can unlock new proteins for novel functions. Aether’s AI is being built on an entirely proprietary dataset developed in-house through advanced high-throughput screening and innovative assay technology. Using this platform, Aether has developed seven new classes of proteins with capabilities ranging from refining metals at lower cost and breaking down persistent “forever chemicals” to producing industry-leading materials, enabling complex pharmaceutical manufacturing, recycling plastics, and capturing carbon dioxide. Aether is already translating its AI breakthroughs into practice, commercializing high-performance materials that can print ten times faster than current industry benchmarks while offering superior strength for the defense and aerospace industries.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aether Biomachines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsErik F., Chief Operating Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aether Biomachines's next move

See what Strategic adds

Aether Biomachines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.